All Sessions by Devin Jackson
5:15 pm
-
7:00 pm
POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury
4:30 pm
-
6:30 pm
POA.08 - Mechanistically Anchored Age-Adjusted Trajectories of neoGFAP™ as a Blood Biomarker for Pediatric Traumatic Brain Injury Monitoring: Pilot Studies with NfL
4:30 pm
-
6:30 pm